Laborator Pharmaceuticals FranceAOP Orphan Pharmaceuticals France

Farmaci commercializzati

• BESREMI 250 µg/0,5 ml Prerempli SOL SINDARE (sostituisce PEGASYS 90 µg/135µg/180 de stock) || 259
• ESMOCARD 100 mg/10 ml sol inj
• Esmocard 2500 mg PDRE P SOL DIL P SOL PF Perf
• RAPIBLOloc 20 mg/2 ml SOL Diluer Inj
• Rapibloc 300 mg PDRE PDRE || ML Sol Diluer P Perf
• REVERPLEG 40 UI/2 ml sol diluer p perf
• Treposuvi 1 mg/ml sol per perf
• Treposuvi 10 mg/ml Sol P Perf
• Treposuvi 2,5 mg/ml Sol P Perf
• Treposuvi 5 mg/ml Sol P Perf || Prodotto